Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Commodities

Commodities

Advertisement

Beverages Explore this Topic

Latest From

KindredBio to raise new funding for extra approvals and R&D

Kindred Biosciences will issue a public offering of its common stock, as it nears extra product approvals.

Kindred Biosciences R&D

Ceva-Phylaxia constructing new plant in Hungary

French firm Ceva Santé Animale is constructing a new vaccine plant and R&D center in Hungary.

Hungary Ceva Sante Animale

Skretting reveals production potential of new Indian aqua site

A joint venture between Skretting's new aquafeed site and Indian firm West Coast Group intends to support India's growing aquaculture industry.

India Operations

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Steven St. Peter resigns, as Craig Tooman takes top job at Aratana

There has been a significant change at the top for Aratana Therapeutics, with Craig Tooman replacing Steven St. Peter.

Aratana Therapeutics People

Pirbright study establishes PPR vaccination cost framework

A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.

Research Vaccines

Canned & Tomato Products Explore this Topic

Latest From

KindredBio to raise new funding for extra approvals and R&D

Kindred Biosciences will issue a public offering of its common stock, as it nears extra product approvals.

Kindred Biosciences R&D

Ceva-Phylaxia constructing new plant in Hungary

French firm Ceva Santé Animale is constructing a new vaccine plant and R&D center in Hungary.

Hungary Ceva Sante Animale

Skretting reveals production potential of new Indian aqua site

A joint venture between Skretting's new aquafeed site and Indian firm West Coast Group intends to support India's growing aquaculture industry.

India Operations

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Steven St. Peter resigns, as Craig Tooman takes top job at Aratana

There has been a significant change at the top for Aratana Therapeutics, with Craig Tooman replacing Steven St. Peter.

Aratana Therapeutics People

Pirbright study establishes PPR vaccination cost framework

A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.

Research Vaccines

Latest From

KindredBio to raise new funding for extra approvals and R&D

Kindred Biosciences will issue a public offering of its common stock, as it nears extra product approvals.

Kindred Biosciences R&D

Ceva-Phylaxia constructing new plant in Hungary

French firm Ceva Santé Animale is constructing a new vaccine plant and R&D center in Hungary.

Hungary Ceva Sante Animale

Skretting reveals production potential of new Indian aqua site

A joint venture between Skretting's new aquafeed site and Indian firm West Coast Group intends to support India's growing aquaculture industry.

India Operations

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Steven St. Peter resigns, as Craig Tooman takes top job at Aratana

There has been a significant change at the top for Aratana Therapeutics, with Craig Tooman replacing Steven St. Peter.

Aratana Therapeutics People

Pirbright study establishes PPR vaccination cost framework

A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.

Research Vaccines

Latest From

KindredBio to raise new funding for extra approvals and R&D

Kindred Biosciences will issue a public offering of its common stock, as it nears extra product approvals.

Kindred Biosciences R&D

Ceva-Phylaxia constructing new plant in Hungary

French firm Ceva Santé Animale is constructing a new vaccine plant and R&D center in Hungary.

Hungary Ceva Sante Animale

Skretting reveals production potential of new Indian aqua site

A joint venture between Skretting's new aquafeed site and Indian firm West Coast Group intends to support India's growing aquaculture industry.

India Operations

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Steven St. Peter resigns, as Craig Tooman takes top job at Aratana

There has been a significant change at the top for Aratana Therapeutics, with Craig Tooman replacing Steven St. Peter.

Aratana Therapeutics People

Pirbright study establishes PPR vaccination cost framework

A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.

Research Vaccines

Latest From

KindredBio to raise new funding for extra approvals and R&D

Kindred Biosciences will issue a public offering of its common stock, as it nears extra product approvals.

Kindred Biosciences R&D

Ceva-Phylaxia constructing new plant in Hungary

French firm Ceva Santé Animale is constructing a new vaccine plant and R&D center in Hungary.

Hungary Ceva Sante Animale

Skretting reveals production potential of new Indian aqua site

A joint venture between Skretting's new aquafeed site and Indian firm West Coast Group intends to support India's growing aquaculture industry.

India Operations

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Steven St. Peter resigns, as Craig Tooman takes top job at Aratana

There has been a significant change at the top for Aratana Therapeutics, with Craig Tooman replacing Steven St. Peter.

Aratana Therapeutics People

Pirbright study establishes PPR vaccination cost framework

A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.

Research Vaccines

Dried Fruit & Nuts Explore this Topic

Latest From

KindredBio to raise new funding for extra approvals and R&D

Kindred Biosciences will issue a public offering of its common stock, as it nears extra product approvals.

Kindred Biosciences R&D

Ceva-Phylaxia constructing new plant in Hungary

French firm Ceva Santé Animale is constructing a new vaccine plant and R&D center in Hungary.

Hungary Ceva Sante Animale

Skretting reveals production potential of new Indian aqua site

A joint venture between Skretting's new aquafeed site and Indian firm West Coast Group intends to support India's growing aquaculture industry.

India Operations

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Steven St. Peter resigns, as Craig Tooman takes top job at Aratana

There has been a significant change at the top for Aratana Therapeutics, with Craig Tooman replacing Steven St. Peter.

Aratana Therapeutics People

Pirbright study establishes PPR vaccination cost framework

A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.

Research Vaccines

Fresh Fruit & Veg Explore this Topic

Latest From

KindredBio to raise new funding for extra approvals and R&D

Kindred Biosciences will issue a public offering of its common stock, as it nears extra product approvals.

Kindred Biosciences R&D

Ceva-Phylaxia constructing new plant in Hungary

French firm Ceva Santé Animale is constructing a new vaccine plant and R&D center in Hungary.

Hungary Ceva Sante Animale

Skretting reveals production potential of new Indian aqua site

A joint venture between Skretting's new aquafeed site and Indian firm West Coast Group intends to support India's growing aquaculture industry.

India Operations

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Steven St. Peter resigns, as Craig Tooman takes top job at Aratana

There has been a significant change at the top for Aratana Therapeutics, with Craig Tooman replacing Steven St. Peter.

Aratana Therapeutics People

Pirbright study establishes PPR vaccination cost framework

A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.

Research Vaccines

Frozen Foods Explore this Topic

Latest From

KindredBio to raise new funding for extra approvals and R&D

Kindred Biosciences will issue a public offering of its common stock, as it nears extra product approvals.

Kindred Biosciences R&D

Ceva-Phylaxia constructing new plant in Hungary

French firm Ceva Santé Animale is constructing a new vaccine plant and R&D center in Hungary.

Hungary Ceva Sante Animale

Skretting reveals production potential of new Indian aqua site

A joint venture between Skretting's new aquafeed site and Indian firm West Coast Group intends to support India's growing aquaculture industry.

India Operations

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Steven St. Peter resigns, as Craig Tooman takes top job at Aratana

There has been a significant change at the top for Aratana Therapeutics, with Craig Tooman replacing Steven St. Peter.

Aratana Therapeutics People

Pirbright study establishes PPR vaccination cost framework

A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.

Research Vaccines

Grains & Feed Explore this Topic

Latest From

KindredBio to raise new funding for extra approvals and R&D

Kindred Biosciences will issue a public offering of its common stock, as it nears extra product approvals.

Kindred Biosciences R&D

Ceva-Phylaxia constructing new plant in Hungary

French firm Ceva Santé Animale is constructing a new vaccine plant and R&D center in Hungary.

Hungary Ceva Sante Animale

Skretting reveals production potential of new Indian aqua site

A joint venture between Skretting's new aquafeed site and Indian firm West Coast Group intends to support India's growing aquaculture industry.

India Operations

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Steven St. Peter resigns, as Craig Tooman takes top job at Aratana

There has been a significant change at the top for Aratana Therapeutics, with Craig Tooman replacing Steven St. Peter.

Aratana Therapeutics People

Pirbright study establishes PPR vaccination cost framework

A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.

Research Vaccines

Oils & Oilseeds Explore this Topic

Latest From

KindredBio to raise new funding for extra approvals and R&D

Kindred Biosciences will issue a public offering of its common stock, as it nears extra product approvals.

Kindred Biosciences R&D

Ceva-Phylaxia constructing new plant in Hungary

French firm Ceva Santé Animale is constructing a new vaccine plant and R&D center in Hungary.

Hungary Ceva Sante Animale

Skretting reveals production potential of new Indian aqua site

A joint venture between Skretting's new aquafeed site and Indian firm West Coast Group intends to support India's growing aquaculture industry.

India Operations

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Steven St. Peter resigns, as Craig Tooman takes top job at Aratana

There has been a significant change at the top for Aratana Therapeutics, with Craig Tooman replacing Steven St. Peter.

Aratana Therapeutics People

Pirbright study establishes PPR vaccination cost framework

A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.

Research Vaccines

Spices & Exotics Explore this Topic

Latest From

KindredBio to raise new funding for extra approvals and R&D

Kindred Biosciences will issue a public offering of its common stock, as it nears extra product approvals.

Kindred Biosciences R&D

Ceva-Phylaxia constructing new plant in Hungary

French firm Ceva Santé Animale is constructing a new vaccine plant and R&D center in Hungary.

Hungary Ceva Sante Animale

Skretting reveals production potential of new Indian aqua site

A joint venture between Skretting's new aquafeed site and Indian firm West Coast Group intends to support India's growing aquaculture industry.

India Operations

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Steven St. Peter resigns, as Craig Tooman takes top job at Aratana

There has been a significant change at the top for Aratana Therapeutics, with Craig Tooman replacing Steven St. Peter.

Aratana Therapeutics People

Pirbright study establishes PPR vaccination cost framework

A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.

Research Vaccines

Latest From

KindredBio to raise new funding for extra approvals and R&D

Kindred Biosciences will issue a public offering of its common stock, as it nears extra product approvals.

Kindred Biosciences R&D

Ceva-Phylaxia constructing new plant in Hungary

French firm Ceva Santé Animale is constructing a new vaccine plant and R&D center in Hungary.

Hungary Ceva Sante Animale

Skretting reveals production potential of new Indian aqua site

A joint venture between Skretting's new aquafeed site and Indian firm West Coast Group intends to support India's growing aquaculture industry.

India Operations

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Steven St. Peter resigns, as Craig Tooman takes top job at Aratana

There has been a significant change at the top for Aratana Therapeutics, with Craig Tooman replacing Steven St. Peter.

Aratana Therapeutics People

Pirbright study establishes PPR vaccination cost framework

A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.

Research Vaccines
UsernamePublicRestriction

Register